ALEMBIC PHARMACEUTICALS
Back to Balance Sheet
|
ALEMBIC PHARMACEUTICALS Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹7,709 Cr | ₹6,341 Cr | ₹6,064 Cr | ₹7,230 Cr | ₹6,961 Cr |
What is the latest Total Liabilities ratio of ALEMBIC PHARMACEUTICALS ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹7,709 Cr |
| Mar2024 | ₹6,341 Cr |
| Mar2023 | ₹6,064 Cr |
| Mar2022 | ₹7,230 Cr |
| Mar2021 | ₹6,961 Cr |
How is Total Liabilities of ALEMBIC PHARMACEUTICALS Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹7,709 Cr | 21.57 | |
| Mar2024 | ₹6,341 Cr | 4.58 | |
| Mar2023 | ₹6,064 Cr | -16.13 | |
| Mar2022 | ₹7,230 Cr | 3.86 | |
| Mar2021 | ₹6,961 Cr | - | |
Compare Total Liabilities of peers of ALEMBIC PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALEMBIC PHARMACEUTICALS | ₹15,037.0 Cr | 0.4% | -10.3% | -25.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹386,329.0 Cr | -0.2% | -6.3% | -8.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹164,674.0 Cr | 3.3% | -3.4% | 4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹133,891.0 Cr | -0.7% | 3.8% | 26.3% | Stock Analytics | |
| CIPLA | ₹107,292.0 Cr | -3% | -11.8% | -8.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,184.0 Cr | 6% | -3.5% | -4.3% | Stock Analytics | |
ALEMBIC PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALEMBIC PHARMACEUTICALS | 0.4% |
-10.3% |
-25.8% |
| SENSEX | 0.2% |
-3.6% |
8.6% |
You may also like the below Video Courses